131 related articles for article (PubMed ID: 19647430)
1. N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.
Wakenhut F; Allan GA; Fish PV; Fray MJ; Harrison AC; McCoy R; Phillips SC; Ryckmans T; Stobie A; Westbrook D; Westbrook SL; Whitlock GA
Bioorg Med Chem Lett; 2009 Sep; 19(17):5078-81. PubMed ID: 19647430
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.
Fish PV; Wakenhut F; Ryckmans T; Stobie A
Bioorg Med Chem Lett; 2009 Aug; 19(16):4579-83. PubMed ID: 19616432
[TBL] [Abstract][Full Text] [Related]
3. 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.
Fish PV; Andrews MD; Jonathan Fray M; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2009 May; 19(10):2829-34. PubMed ID: 19359175
[TBL] [Abstract][Full Text] [Related]
4. N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.
Wakenhut F; Fish PV; Fray MJ; Gurrell I; Mills JE; Stobie A; Whitlock GA
Bioorg Med Chem Lett; 2008 Aug; 18(15):4308-11. PubMed ID: 18625557
[TBL] [Abstract][Full Text] [Related]
5. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
Meltzer PC; Butler D; Deschamps JR; Madras BK
J Med Chem; 2006 Feb; 49(4):1420-32. PubMed ID: 16480278
[TBL] [Abstract][Full Text] [Related]
6. Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.
Fish PV; Barta NS; Gray DL; Ryckmans T; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2008 Aug; 18(15):4355-9. PubMed ID: 18621528
[TBL] [Abstract][Full Text] [Related]
7. Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.
Fray MJ; Fish PV; Allan GA; Bish G; Clarke N; Eccles R; Harrison AC; Le Net JL; Phillips SC; Regan N; Sobry C; Stobie A; Wakenhut F; Westbrook D; Westbrook SL; Whitlock GA
Bioorg Med Chem Lett; 2010 Jun; 20(12):3788-92. PubMed ID: 20471260
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.
Lucas MC; Weikert RJ; Carter DS; Cai HY; Greenhouse R; Iyer PS; Lin CJ; Lee EK; Madera AM; Moore A; Ozboya K; Schoenfeld RC; Steiner S; Zhai Y; Lynch SM
Bioorg Med Chem Lett; 2010 Sep; 20(18):5559-66. PubMed ID: 20691589
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ
Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106
[TBL] [Abstract][Full Text] [Related]
11. N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.
Fish PV; Fray MJ; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2007 Apr; 17(7):2022-5. PubMed ID: 17267217
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
Gong PK; Blough BE; Brieaddy LE; Huang X; Kuhar MJ; Navarro HA; Carroll FI
J Med Chem; 2007 Jul; 50(15):3686-95. PubMed ID: 17602602
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.
Shao L; Ma J; Wang F; Malcolm SC; Hewitt MC; Campbell UC; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem Lett; 2011 Jan; 21(1):520-3. PubMed ID: 21095126
[TBL] [Abstract][Full Text] [Related]
14. 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.
Micheli F; Cavanni P; Bettati M; Bonanomi G; Di Fabio R; Fazzolari E; Marchioro C; Roscic M; Tarsi L; Visentini F; Zonzini L; Worby A
Bioorg Med Chem; 2011 Jun; 19(11):3451-61. PubMed ID: 21550808
[TBL] [Abstract][Full Text] [Related]
15. Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
Bannwart LM; Carter DS; Cai HY; Choy JC; Greenhouse R; Jaime-Figueroa S; Iyer PS; Lin CJ; Lee EK; Lucas MC; Lynch SM; Madera AM; Moore A; Ozboya K; Raptova L; Roetz R; Schoenfeld RC; Stein KA; Steiner S; Villa M; Weikert RJ; Zhai Y
Bioorg Med Chem Lett; 2008 Dec; 18(23):6062-6. PubMed ID: 18954985
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
Lukas RJ; Muresan AZ; Damaj MI; Blough BE; Huang X; Navarro HA; Mascarella SW; Eaton JB; Marxer-Miller SK; Carroll FI
J Med Chem; 2010 Jun; 53(12):4731-48. PubMed ID: 20509659
[TBL] [Abstract][Full Text] [Related]
17. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.
Carroll FI; Blough BE; Abraham P; Mills AC; Holleman JA; Wolckenhauer SA; Decker AM; Landavazo A; McElroy KT; Navarro HA; Gatch MB; Forster MJ
J Med Chem; 2009 Nov; 52(21):6768-81. PubMed ID: 19821577
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition.
Smid P; Coolen HK; Keizer HG; van Hes R; de Moes JP; den Hartog AP; Stork B; Plekkenpol RH; Niemann LC; Stroomer CN; Tulp MT; van Stuivenberg HH; McCreary AC; Hesselink MB; Herremans AH; Kruse CG
J Med Chem; 2005 Nov; 48(22):6855-69. PubMed ID: 16250644
[TBL] [Abstract][Full Text] [Related]
20. Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties.
Cordi AA; Berque-Bestel I; Persigand T; Lacoste JM; Newman-Tancredi A; Audinot V; Millan MJ
J Med Chem; 2001 Mar; 44(5):787-805. PubMed ID: 11262089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]